期刊文献+

环氧合酶-2在大肠癌组织中的表达及临床意义的研究 被引量:1

Expression and Clinical Significance of COX-2 in Colorectal Carcinoma
下载PDF
导出
摘要 目的 探讨COX-2蛋白在大肠癌中的表达与肿瘤发生发展和转移的关系.方法 应用免疫组化SP法检测COX-2蛋白在66例大肠癌及22例正常大肠组织的表达情况.结果 COX-2蛋白在66例大肠癌组织中高表达(56/66),阳性表达率84.8%,与正常大肠组织相比差异有显著性(P<0.01);COX-2蛋白的表达与肿瘤组织的浸润深度显著相关(P<0.05);与Dukes分期呈正相关(P<0.05);淋巴结有转移组与无转移组差异有显著性(P<0.05).结论 COX-2在大肠癌的发生、发展及浸润、转移过程中发挥着重要作用,可望成为预测大肠癌恶性潜能的临床指标之一. Objective To investigate the expression of COX-2 in a series of colorectal neoplasm and its relation to the development of colorectal carcinoma. Methods The immunohistochemical staining with SP method was used to detect the COX-2 expression in paraffin sections from 66 patients with colorectal carcinoma, 22 normal mucosal tissues. Results The positive rate of COX-2 (84.8 % ) in colorectal carcinoma was significantly higher than that in normal mucosal tissues( P 〈 0.01) ; The expression of COX-2 is significantly correlated to depth of invasion(P 〈 0.05) and Dukes stage( P 〈 0.05), and is much higher in tumor tissue with positive-node than that with negative-node ( P 〈 0.05). Conclusion COX-2 might play a key role in the occurrence and development of invasion and metastasis in colorectal carcinoma. Overexpression of COX-2 may serve as a valuable predictor for tumor metastatic potential in colorectal carcinoma.
机构地区 北华大学医学院
出处 《北华大学学报(自然科学版)》 CAS 2007年第3期248-250,共3页 Journal of Beihua University(Natural Science)
关键词 大肠癌 环氧合酶-2 免疫组织化学 Colorectal carcinoma Cyclooxygenase-2 Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献35

  • 1Williams CS, Mann M, DuBios RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18:7908-7916.
  • 2Egil F. Biochemistry of cyclooxygenase (COX-2) inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000; 37:431-502.
  • 3Subbaramaiah K, Dannenberg AJ. Cyclooxygenase2: a molecular target for cancer prevention and treatment. Trends Pharmaco Sci 2003; 24: 96-102.
  • 4Thun MJ, Hennekenn CH. Aspirin and other non-steroidal antiinflammatory drugs and the risk of cancer development. In:DeVitt VT, Hellman S, Rosenberg SA. Cancer: principles and pracrice of oncology. 6^th edition. Philadelphia: Lippincott Williams &Wilkins Press, U S A 2001:601-607.
  • 5Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998: 58:409412.
  • 6Reddy BS, Rao CV, Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996; 56:4566-4569.
  • 7Dannenberg AJ, Zakim D. chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol 1999;26:499-504.
  • 8Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
  • 9Dicato M, Berchem G, Duhem C, Ries F. The biology of colorectal cancer. Semin Oncol 2000; 27(5 Suppl 10): 2-9.
  • 10Kononen J, Bubendorf L, Kalliolniemi A, Barlund M, Schraml P,Leighton S, Torhorst J, Mihatsch MJ, Sauter G, KaUioniemi OP.Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat ivied 1998; 4:844-847.

共引文献38

同被引文献7

  • 1Williams C,Shattuck-Brandt R L,DuBios R N,et al.The Role of Cox-2 in Intestinal Cancer[J].Ann N Y Acacl Sci,1999,889:72-83.
  • 2Soslow R A,Dannenberg A J,Rush D,et al.COX-2 is Expressed in Human Pulmonary,Colonic,and Mammary Tumors[J].Cancer,2000,89:2637-2645.
  • 3Yamauchi T,Watanabe M,Kubota T,et al.Cycloo xy genase-2 Expression as a New Marker for Patients with Colorectal Cancer[J].Dis Colon Rectum 2002,45:98-103.
  • 4Soumaoro L T,Uetake H,Higuchi T,et al.Cycloo xygenase-2 Expression:a Significant Prognostic Indicator for Patients with Colorectal Cancer[J].Clin Cancer Res,2004,10(24):8465-8471.
  • 5Sun W H,Sun Y L,Fang R N,et al.Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and Its Correlation with Angiogenesis[J].Japanese Journal of Clinical Oncology,2005,35(12):707-713.
  • 6Karaha N,Guney M,Baspinar S,et al.Expression of Gelatinase(MMP-2 and MMP-9) and Cyclooxygenase-2(COX-2) in Endometrial Carcinoma[J].Eur J Gynaecol Oncol,2007,28(3):184-186.
  • 7Iwasaki A,Kuwahara,Yoshinaga Y,et al.Basic Fibroblast Growth Factor(bFGF) and Vascular Endothelial Growth Factor(VEGF) Levels,as Prognostic Indicators in NSCLC[J].Eur J Cardiothorac Surg,2004,25:443-448.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部